Great Lakes Advisors
GBT

Great Lakes Advisors’s Global Blood Therapeutics, Inc. GBT Stock Holding History

Great Lakes Advisors’s Portfolio GBT Stock Details GBT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-161,130
Closed -$8.48M – 586
2019
Q2 		$8.48M Buy
+161,130
New +$9.26M 0.18% 129
2017
Q4 		– Sell
-18,084
Closed -$562K – 625
2017
Q3 		$562K Buy
+18,084
New +$509K 0.01% 429

Other funds holding GBT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Perceptive Advisors
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Farallon Capital Management
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return

Great Lakes Advisors's GBT Position: Q3 2019 in Review

Great Lakes Advisors sold out of Global Blood Therapeutics, Inc. (GBT) in Q3 2019, closing a stake of 161,130 shares — an estimated $8.48M sold.

Great Lakes Advisors first reported a position in GBT in Q3 2017 and held it in 2 quarters. The position peaked at $8.48M in Q2 2019. 208 funds tracked by Wall St. Rank hold GBT as of Q3 2019.

  • Great Lakes Advisors reported no remaining Global Blood Therapeutics, Inc. position as of Q3 2019 after selling out during the quarter.
  • Great Lakes Advisors sold 161,130 Global Blood Therapeutics, Inc. shares in Q3 2019, an estimated $8.48M.
  • Great Lakes Advisors first reported a position in Global Blood Therapeutics, Inc. in Q3 2017 and held it in 2 quarters.
  • Great Lakes Advisors's Global Blood Therapeutics, Inc. position peaked at $8.48M in Q2 2019.
  • 208 funds tracked by Wall St. Rank held Global Blood Therapeutics, Inc. as of Q3 2019.

Based on Great Lakes Advisors's 13F filing for Q3 2019, filed 6 Nov 2019.